SJMC partners with Mayo Clinic Labs to enhance services

SJMC, a flagship under RSDH, joins hands with Mayo Clinic Laboratories to offer specialised diagnostic tests, bolstering Malaysia’s healthcare landscape.

Close-up of machine running sample analysis. Asset taken as part of campaign to highlight the work of Mayo Validation Support Services (MVSS) and the Forensic Toxicology Labs.

In a significant development for Malaysia’s healthcare landscape, Ramsay Sime Darby Health Care (RSDH) has joined forces with Mayo Clinic Laboratories, the esteemed global reference laboratory of Mayo Clinic.

The collaboration aims to bring esoteric laboratory services to RSDH patients, with Subang Jaya Medical Centre (SJMC), as the flagship hospital, serving as the centralised referral hub for laboratory tests across all RSDH hospitals.

Elevating diagnostic capabilities

Close-up of Niki Parikh, MD, MBA, Urology Resident, looking at samples under a microscope. Asset taken to highlight the Urology Residency program at Mayo Clinic.

Under the reference laboratory service agreement, SJMC will channel select specialised tests to Mayo Clinic Laboratories in Rochester, Minnesota, USA, for analysis.

These tests encompass critical domains like neurology, haematology, and oncology evaluations, aligning closely with the core focus areas and Centre of Excellence of RSDH hospitals. The significance lies in their pivotal role in ensuring accurate disease diagnosis.

See also  Stemcell First revolutionises cancer care and prevention

This collaboration represents a stride towards elevating diagnostic capabilities in Malaysian healthcare. SJMC, leveraging the expertise and advanced technology of Mayo Clinic Laboratories, aspires to deliver precise and effective treatment plans to patients, significantly enhancing patient care and outcomes.

Advancing healthcare expertise

Harmeet Malhi, Consultant in the Division of Gastroenterology and Hepatology, using pipette to work with samples. Asset taken for Discovery’s Edge magazine.

Peter Hong, Group Chief Executive Officer of RSDH, expressed enthusiasm for this milestone agreement. He underscored the shared objective of advancing healthcare knowledge and expertise, emphasizing that the partnership enables patients to access specialised tests previously unavailable in the region. This collaboration underscores RSDH’s unwavering commitment to delivering high-quality healthcare services.

Bryan Lin, Chief Executive Officer of SJMC, highlighted the potential for precise diagnosis through this collaboration. It equips doctors with the tools to offer tailored treatment options, ultimately improving patient outcomes.

See also  OncoCare brings top cancer care to Malaysia

Emphasizing SJMC’s status as a flagship hospital for the Malaysia Healthcare Travel Council (MHTC), he anticipates that this partnership will strengthen trust in their clinical outcomes.

The collaboration between Mayo Clinic Laboratories and SJMC, under the umbrella of RSDH, represents a pioneering effort to elevate diagnostic services in Malaysia.

By leveraging the global expertise of Mayo Clinic Laboratories, RSDH hospitals aim to provide patients with world-class healthcare options, placing precise diagnoses and effective treatments within closer reach.

RSDH is committed to delivering exceptional healthcare services in Malaysia. For more information on RSDH, visit their website at https://www.ramsaysimedarby.com/.

Avatar photo

CJMY

For any inquiries or to submit a press release, please send an email CJ Editor at [email protected].